Shukra Pharmaceuticals P/E Ratio
Shukra Pharmaceuticals (SHUKRAPHAR) P/E ratio is not applicable — EPS (TTM) ₹0.50, 1 consecutive loss quarter. See Healthcare peers with valid P/E ratios below.
P/E Ratio Status
N/A
Loss Making
Company is currently reporting losses
P/E Ratio Not Applicable
Company reported a loss in the most recent quarter. P/E ratio is not meaningful for loss-making periods.
Consecutive Loss Quarters: 1
Current EPS: ₹0.50
Recent Quarterly Performance
| Quarter | EPS (₹) | Net Profit (₹ Cr) | Status |
|---|---|---|---|
| Mar 2026 | -0.04 | -2 | Loss |
| Jun 2026 | 0.30 | 13 | Profit |
| Sept 2025 | 0.05 | 2 | Profit |
| Mar 2025 | 0.12 | 5 | Profit |
| Jun 2025 | 0.02 | 1 | Profit |
| Dec 2025 | 0.47 | 20 | Profit |
| Dec 2024 | 0.72 | 3 | Profit |
Healthcare Peers with Valid P/E Ratios — SHUKRAPHAR Comparison
Healthcare sector average P/E 56.67, median 31.66 — SHUKRAPHAR excluded (negative EPS).
Sector Average PE
56.67
Sector Median PE
31.66
Lowest PE
1.99
Profitable Companies
199
| Company | Symbol | P/E Ratio | Market Cap (₹ Cr) | Valuation |
|---|---|---|---|---|
| Sunrest Lifescience | SUNREST | 1.99 | ₹66 | Low |
| Murae Organisor | MURAE | 2.86 | ₹41 | Low |
| Colinz Laboratories | COLINZ | 3.27 | ₹9 | Low |
| Phaarmasia | PHRMASI | 3.41 | ₹59 | Low |
| Sun Pharma Advanced Rese… | SPARC | 4.03 | ₹6,361 | Low |
| Dipna Pharmachem | DPL | 4.65 | ₹12 | Low |
| JFL Life Sciences | JFLLIFE | 4.95 | ₹67 | Low |
| Shelter Pharma | SHELTER | 5.71 | ₹56 | Low |
| GKB Ophthalmics | GKB | 5.9 | ₹33 | Low |
| Kabra Drugs | KABRADG | 6.29 | ₹49 | Low |
Related Analysis
- For live price, revenue and the complete fundamental profile, see Shukra Pharmaceuticals share price screener.
- Also explore SHUKRAPHAR share price data to track price trends across different timeframes.